Articles: PubMed: A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. PubMed: Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion. PubMed: Determination of phenolic acids in plant extracts using CZE with on-line transient isotachophoretic preconcentration. PubMed: Phenolic compounds in five Epilobium species collected from Estonia. PubMed: Search for a plant for phytoremediation--what can we learn from field and hydroponic studies? PubMed: [Epilobium parviflorum--in vitro study of biological action]. PubMed: Antioxidant and antiinflammatory effect of Epilobium parviflorum Schreb. PubMed: Polyphenol composition and antioxidant capacity of Epilobium species. PubMed: The effect of chitosan on the stability and morphological parameters of tablets with Epilobium parviflorum Schreb. extract. PubMed: Application of silicified microcrystalline cellulose (Prosolv) as a polymer carrier of Epilobium parviflorum Schreb. extract in oral solid drug form. PubMed: Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis. PubMed: Photoprotection by topical application of Achyrocline satureioides ('Marcela'). PubMed: Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. PubMed: Determination of oenothein B as the active 5-alpha-reductase-inhibiting principle of the folk medicine Epilobium parviflorum.